Concentrix (US.CNXC)
Capital Allocation Audit · Period: 2013 – 2026
Key Metrics
US.CNXC · YoY: 2026 H1 vs 2025 H1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 41.6% | ↓ |
| ROE | 2.7% | ↑ |
| Cash Conversion | 239.3% | ↑ |
| D/E Ratio | 1.70 | ↓ |
| Gross Margin | 33.7% | ↓ |
US.CNXC (Concentrix) | YoY: 2026 H1 vs 2025 H1 Metric Value YoY ---------------------------- FCF Conversion 41.6% ↓ ROE 2.7% ↑ Cash Conversion 239.3% ↑ D/E Ratio 1.70 ↓ Gross Margin 33.7% ↓
Key Metrics
US.CNXC (Concentrix) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY----------------------------FCF Conversion 41.6% ↓ROE 2.7% ↑Cash Conversion 239.3% ↑D/E Ratio 1.70 ↓Gross Margin 33.7% ↓Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies